Сучасні аспекти вакцинації дітей із ревматичними захворюваннями (огляд літератури)

Ya. Romanyshyn, L. Kostiuchenko, Ya. Boiko

Анотація


Вакцинація – найефективніший спосіб захисту від інфекційних хвороб. Дітям із ревматичними захворюваннями (РЗ) властивий підвищений ризик інфекцій, оскільки вплив на функції імунної системи мають як саме ревматичне захворювання, так і терапія, що призначається для його контролю. У статті аналізуються наявні в літературі дані стосовно вакцино-асоційованого ризику автоімунних реакцій, а також ефективності й переносимості щеплень у дітей із РЗ, наводяться сучасні рекомендації експертів стосовно тактики імунізації цієї категорії пацієнтів.


Ключові слова


діти; ревматичні захворювання; вакцинація; імуносупресивна терапія

Повний текст:

PDF

Посилання


Slater PE, Ben-Zvi T, Fogel A. Absence of an association between rubella vaccination and arthritis in underimmune postpartum women. Vaccine. 1995;13:1529-532.

Kashef S, Ghazizadeh F, Derakhshan A. Antigen-specific antibody response in juvenile-onset SLE patients following routine immunization with tetanus toxoid.Iran J. Immunol. 2008;5:181-84.

Bongartz T, Sutton AJ, Sweeting MJ. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA. 2006;295:2275-285.

De Stefano F, Mullooly JP, Okoro CA. Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus. Pediatrics. 2001;108:112.

Conti F, Rezai S, Valesini G. Vaccination and autoimmune rheumatic diseases. Autoimmun Rev. 2008;8:124-28.

Grézard P, Chefa M, Philippot V. Cutaneous lupus erythematosus and buccal aphthosis after hepatitis B vaccination in a 6-year-old child. Ann. Dermatol. Venereol. 1996;123:657-59.

Ventura F, Antunes H, Brito C. Cutaneous polyarteritis nodosa in a child following hepatitis B vaccination. Eur. J. Dermatol. 2009;19:400-401.

Davies K, Woo P. Immunization in rheumatic diseases of childhood: an audit of the clinical practice of British Paediatric Rheumatology Group members and a review of the evidence. Rheumatology. 2002;41:937-41.

de Carvalho JF, Pereira RM, Shoenfeld Y. Systemic polyarteritis nodosa following hepatitis B vaccination. Eur. J. Intern. Med. 2008;19:575-78.

Duclos P. Safety of immunization and adverse events following vaccination against hepatitis B. Expert Opin. Drug. Saf. 2003;2:225-31.

Borte S, Liebert UG, Borte M, Sack U. Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept. Rheumatology. 2009;48:144-48.

Elkayam O, Ablim J, Caspi D. Safety and efficacy of vaccination against Streptococcus pneumoniae in patients with rheumatic diseases. Autoimmun Rev. 2007;6:312-14.

Esposito S, Principi N. The rational use of influenza vaccines in healthy children and children with underlying conditions. Curr. Opin. Infect. Dis. 2009;22:244-49.

Heijstek MW, Ott de Bruin LM, Bijl M. EULAR recommendations for vaccination in paediatric patients with rheumatic diseases. Rheum. Dis. 2011;70:1704-712.

Kasapçopur O, Cullu F, Kamburoğlu-Goksel A. Hepatitis B vaccination in children with juvenile idiopathic arthritis. Ann. Rheum. Dis. 2004;63:1128-130.

van Assen S, Holvast A, Benne CA. Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab. Arthritis Rheum. 2010;62:75-81.

Kaine JL, Kivitz AJ, Birbara C. Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab. J. Rheumatol. 2007;34:272-79.

De Keyser F, Naeyaert JM, Hindryckx P. Immune-mediated pathology following hepatitis B vaccination.Two cases of polyarteritis nodosa and one case of pityriasis rosea-like eruption. Clin. Exp. Rheumatol. 2000;18:81-5.

Elkayam O, Paran D, Caspi D. Immunogenicity and safety of pneumococcal vaccination in patients with rheumatoid arthritis or systemic lupus erythematosus. Clin. Infect. Dis. 2002;34:147-53.

Atzeni F, Bendtzen K, Bobbio-Pallavicini F. Infections and treatment of patients with rheumatic diseases. Clin. Exp. Rheumatol. 2008;26(48):67-73.

Kapetanovic MC, Saxne T, Sjöholm A. Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. Rheumatology. 2006;45:106-11.

Malleson PN, Tekano JL, Scheifele DV. Influenza immunization in children with chronic arthritis: a prospective study. J. Rheumatol. 1993;20:1769-773.

Kapetanovic MC, Saxne T, Nilsson JA, Geborek P. Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis. Rheumatology. 2007;46:608-11.

Kanakoudi-Tsakalidou F, Trachana M, Pratsidou-Gertsi P. Influenza vaccination in children with chronic rheumatic diseases and long-term immunosuppressive therapy. Clin. Exp. Rheumatol. 2001;19:589-94.

Jones CT. Childhood autoimmune neurologic diseases of the central nervous system. Neurol. Clin. 2003;21:745-64.

Koshcheeva IuV, Kharit SM, Kalinina NM. Specific features of diphtheria vaccinal process in children with rheumatic diseases. Zh. Mikrobiol. Epidemiol. Immunobiol. 2001;6:44-9.

Kostinov MP, Tarasova AA, Zaĭtsev EM. Contents of antibodies to Bordetella pertussis antigens in patients with rheumatic diseases. Zh. Mikrobiol. Epidemiol. Immunobiol. 2007;6:61-4.

Miron D, Fink D, Hashkes PJ. Kawasaki disease in an infant following immunisation with hepatitis B vaccine. Clin. Rheumatol. 2003;22:461-63.

Olson NY, Lindsley CB, Page-Goertz S. Influenza immunization in children with chronic arthritis. J. Rheumatol. 1994;21:1581.

Mease PJ, Ritchlin CT, Martin RW. Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept. J. Rheumatol. 2004;31:1356-361.

Prepared by Anthony E. Fiore, Timothy M. Uyeki, Karen Broder. Prevention and control of influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. Centers for Disease Control and Prevention (CDC). Morb. Mortal Wkly Rep. 2010;59:1-8.

Visvanathan S, Keenan GF, Baker DG. Response to pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone. J. Rheumatol. 2007;34:952-57.

Maillefert JF, Sibilia J, Toussirot E. Rheumatic disorders developed after hepatitis B vaccination. Rheumatology. 1999;38:978-83.

Ray P, Black S, Shinefield H. Risk of chronic arthropathy among women after rubella vaccination. J. Am. Med. Assoc. 1997;278:551-56.

Sadovnick AD, Scheifele DW. School-based hepatitis B vaccination programme and adolescent multiple sclerosis. Lancet. 2000;355:549-50.

Heijstek MW, Pileggi GC, Zonneveld-Huijssoon E. Safety of measles, mumps and rubella vaccination in juvenile idiopathic arthritis. Ann. Rheum. Dis. 2007;66:1384-87.

Toussirot E, Lobse A, Wendling D, Mougin C. Sjogren's syndrome occurring after hepatitis B vaccination. Arthritis Rheum. 2000;43:2139-140.

Le Hello C, Cohen P, Bousser MG. Suspected hepatitis B vaccination related vasculitis. J. Rheumatol. 1999;26:191-94.

Pope JE, Stevens A, Howson W, Bell DA. The development of rheumatoid arthritis after recombinant hepatitis B vaccination. J. Rheumatol. 1998;25:1687-93.

Gelinck. LB, van der Bijl AE, Beyer WE. The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination. Ann. Rheum. Dis. 2008;67:713-16.

Elkayam O, Caspi D, Reiblatt T. The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis. Semin. Arthritis Rheum. 2004;33:283-88.

Miller C, Andrews N, Rush M. The epidemiology of subacute sclerosing panencephalitis in England and Wales 1990–2002. Arch. Dis. Child. 2004;89:1145-148.

Dell'Era L, Esposito S, Corona F, Princip N. Vaccination of Children and Adolescents With Rheumatic Diseases. Rheumatology. 2011;50:1358-365.

Zipp F, Weil JG, Einhaupl KM. No increase in demyelinating diseases after hepatitis B vaccination. Nat. Med. 1999;5:964-65.


Пристатейна бібліографія ГОСТ






DOI: https://doi.org/10.24061/114099

Посилання

  • Поки немає зовнішніх посилань.


Copyright (c) 2017 Ya. Romanyshyn, L. Kostiuchenko, Ya. Boiko

Технічний редактор журналу, к.мед.н. М. Степанченко, 2015-2017